创胜集团 - 全整合型国际化生物制药公司

创胜集团, 生物药, 抗体, 药物研发

创胜集团 - 全整合型国际化生物制药公司

加入我们 联系我们

媒体报道

媒体报道

Xueming Qian outlines the new company’s origins, the space it seeks to fill within the highly competitive Chinese oncology market, and where Chinese biotech stands globally in 2019

2019 年 08 月 06 日

Dr Qian, Transcenta was established in January 2019 from the merger of two biotech companies: your company, MabSpace Biosciences and HJB, founded by Jonathan Zhao. What brought both companies together?

There were a number of reasons for the merger. Ultimately, there needed to be a common value proposition for us to work together. Jonathan and I actually worked together at Amgen, one of the world’s leading biotech companies. We both understand the necessary elements for developing, producing and commercializing a biotherapeutic drug, so we share the same value and standards, and knew we could work well together...

查看全文→